These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 511333)

  • 1. Concentrations of nystatin in faeces after oral administration of various doses of nystatin.
    Hofstra W; de Vries-Hospers HG; van der Waaij D
    Infection; 1979; 7(4):166-70. PubMed ID: 511333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioassay for determination of nystatin in faeces after oral application.
    Blaschke-Hellmessen R; Schwarze U
    Mycoses; 1990 Mar; 33(3):129-35. PubMed ID: 2113608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mycologic monitoring of newborn infants at risk during preventive administration of nystatin].
    Blaschke-Hellmessen R; Schwarze R
    Monatsschr Kinderheilkd; 1991 Feb; 139(2):92-5. PubMed ID: 2038353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intestinal excretion of nystatin during and after oral administration to newborn infants at risk].
    Blaschke-Hellmessen R; Pannwitz U; Schwarze R
    Monatsschr Kinderheilkd; 1991 Feb; 139(2):89-91. PubMed ID: 2038352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various doses.
    Hofstra W; de Vries-Hospers HG; van der Waaij D
    Infection; 1982; 10(4):223-7. PubMed ID: 7129644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients.
    Normand S; François B; Dardé ML; Bouteille B; Bonnivard M; Preux PM; Gastinne H; Vignon P
    Intensive Care Med; 2005 Nov; 31(11):1508-13. PubMed ID: 16195905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis.
    DeGregorio MW; Lee WM; Ries CA
    Cancer; 1982 Dec; 50(12):2780-4. PubMed ID: 6958353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit.
    Ozturk MA; Gunes T; Koklu E; Cetin N; Koc N
    Mycoses; 2006 Nov; 49(6):484-92. PubMed ID: 17022766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perianal candidosis--a comparative study with mupirocin and nystatin.
    de Wet PM; Rode H; van Dyk A; Millar AJ
    Int J Dermatol; 1999 Aug; 38(8):618-22. PubMed ID: 10487455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants.
    Goins RA; Ascher D; Waecker N; Arnold J; Moorefield E
    Pediatr Infect Dis J; 2002 Dec; 21(12):1165-7. PubMed ID: 12506950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.
    Melkoumov A; Goupil M; Louhichi F; Raymond M; de Repentigny L; Leclair G
    J Antimicrob Chemother; 2013 Sep; 68(9):2099-105. PubMed ID: 23620465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
    Groll AH; Just-Nuebling G; Kurz M; Mueller C; Nowak-Goettl U; Schwabe D; Shah PM; Kornhuber B
    J Antimicrob Chemother; 1997 Dec; 40(6):855-62. PubMed ID: 9462438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Orally administered nystatin to newborn infants in the prevention of candidiasis].
    Blaschke-Hellmessen R; Schwarze R; Schmeiser H; Weigl I
    Z Gesamte Hyg; 1976 Jul; 22(7):501-9. PubMed ID: 960840
    [No Abstract]   [Full Text] [Related]  

  • 14. Nystatin pastilles and suspension in the treatment of oral candidosis.
    Millns B; Martin MV
    Br Dent J; 1996 Sep; 181(6):209-11. PubMed ID: 8885454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group.
    Young GA; Bosly A; Gibbs DL; Durrant S
    Eur J Cancer; 1999 Aug; 35(8):1208-13. PubMed ID: 10615231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis.
    Lo WK; Chan CY; Cheng SW; Poon JF; Chan DT; Cheng IK
    Am J Kidney Dis; 1996 Oct; 28(4):549-52. PubMed ID: 8840945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind trial of nystatin therapy for the candidiasis hypersensitivity syndrome.
    Dismukes WE; Wade JS; Lee JY; Dockery BK; Hain JD
    N Engl J Med; 1990 Dec; 323(25):1717-23. PubMed ID: 2247104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
    Fan SR; Liu XP
    Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies.
    Aksungur P; Sungur A; Unal S; Iskit AB; Squier CA; Senel S
    J Control Release; 2004 Aug; 98(2):269-79. PubMed ID: 15262418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.
    Lumbreras C; Cuervas-Mons V; Jara P; del Palacio A; Turrión VS; Barrios C; Moreno E; Noriega AR; Paya CV
    J Infect Dis; 1996 Sep; 174(3):583-8. PubMed ID: 8769617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.